SecSonar.com

IRIDEX Corporation (IRIX)

IRIDEX Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

IRIDEX Corporation (IRIX) is a Medical - Devices company based in US with a market capitalization of $17.6M. Revenue grew 8.2% year-over-year and free cash flow was negative at -$2.3M. This page tracks IRIX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 93 employees · IPO Feb 16, 1996

Valuation

Valuation & price

$1.01 · as of May 23, 2026 · -35.3% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

3.57

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$1.56$1.24$0.92Jul 25Dec 25Jul 26Jul 7, 25$0.95Jul 9, 25$1.00Jul 11, 25$1.01Jul 15, 25$1.00Jul 17, 25$1.29Jul 21, 25$1.26Jul 23, 25$1.41Jul 25, 25$1.41Jul 29, 25$1.40Jul 31, 25$1.32Aug 4, 25$1.32Aug 6, 25$1.30Aug 11, 25$1.26Aug 13, 25$1.18Aug 15, 25$1.13Aug 19, 25$1.16Aug 21, 25$1.21Aug 25, 25$1.27Aug 27, 25$1.30Aug 29, 25$1.34Sep 3, 25$1.39Sep 5, 25$1.40Sep 9, 25$1.36Sep 11, 25$1.37Sep 16, 25$1.28Sep 18, 25$1.28Sep 22, 25$1.15Sep 24, 25$1.19Sep 26, 25$1.15Sep 30, 25$1.14Oct 2, 25$1.15Oct 6, 25$1.13Oct 8, 25$1.09Oct 10, 25$1.04Oct 14, 25$1.06Oct 16, 25$1.05Oct 21, 25$1.08Oct 23, 25$1.09Oct 27, 25$1.06Oct 29, 25$1.03Oct 31, 25$1.05Nov 4, 25$1.04Nov 6, 25$1.05Nov 10, 25$1.10Nov 12, 25$0.95Nov 14, 25$0.98Nov 18, 25$0.93Nov 20, 25$0.94Nov 25, 25$0.92Nov 28, 25$0.96Dec 2, 25$0.92Dec 4, 25$0.93Dec 8, 25$0.92Dec 10, 25$0.94Dec 12, 25$0.92Dec 16, 25$1.00Dec 18, 25$0.97Dec 22, 25$1.03Dec 24, 25$1.14Dec 29, 25$1.17Jan 2, 26$1.17Jan 6, 26$1.18Jan 8, 26$1.19Jan 12, 26$1.48Jan 14, 26$1.32Jan 16, 26$1.41Jan 21, 26$1.56Jan 23, 26$1.52Jan 27, 26$1.53Jan 29, 26$1.49Feb 2, 26$1.50Feb 4, 26$1.44Feb 9, 26$1.48Feb 11, 26$1.43Feb 13, 26$1.38Feb 18, 26$1.38Feb 20, 26$1.39Feb 24, 26$1.46Feb 26, 26$1.46Mar 2, 26$1.41Mar 4, 26$1.41Mar 6, 26$1.24Mar 10, 26$1.34Mar 12, 26$1.33Mar 17, 26$1.33Mar 19, 26$1.34Mar 23, 26$1.35Mar 25, 26$1.33Mar 27, 26$0.99Mar 31, 26$1.01Apr 2, 26$0.98Apr 7, 26$1.03Apr 9, 26$1.04Apr 13, 26$1.03Apr 15, 26$1.04Apr 17, 26$1.06Apr 22, 26$1.05Apr 24, 26$1.06Apr 28, 26$1.04Apr 30, 26$1.03May 4, 26$1.09May 6, 26$1.04May 8, 26$1.03May 12, 26$1.04May 14, 26$1.01May 18, 26$1.01May 20, 26$1.00May 22, 26$1.01May 28, 26$1.03Jun 1, 26$1.11Jun 3, 26$1.15Jun 5, 26$1.09Jun 9, 26$1.12Jun 11, 26$1.12Jun 15, 26$1.18Jun 17, 26$1.17Jun 22, 26$1.18Jun 24, 26$1.19Jun 26, 26$1.13Jul 2, 26$1.14
$0.8952-week range$1.56
Loading valuation history…

Fundamentals

Key fundamentals

$17.6M

Market cap

8.2%

Revenue growth (YoY)

36.6%

Gross margin

-$2.3M

Free cash flow (USD)

-$1.5M

Net debt

Net cash position

4.5%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2026

FY 2016$46.2MFY 2017$41.6MFY 2018$42.6MFY 2019$43.4MFY 2020$36.3MFY 2021$53.9MFY 2022$57.0MFY 2023$51.9MFY 2024$48.7MFY 2026$52.7M
$46.2M$52.7M

Free cash flow by year

2016 → 2026

FY 2016$-1.2MFY 2017$-4.1MFY 2018$-10.5MFY 2019$-8.0MFY 2020$-3.3MFY 2021$8.0MFY 2022$-9.8MFY 2023$-6.9MFY 2024$-7.3MFY 2026$-2.3M
-$1.2M-$2.3M

Gross margin by year

2021 → 2026

FY 202142.4%FY 202244.5%FY 202342.0%FY 202440.1%FY 202636.6%
42.4%36.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

6

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 19, 2026 (EPS $-0.03)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting AdjournedJun 18, 2026Filing
  • Insider buyInsider Buy $1KDizon Romeo R · Chief Financial Officer · $1.1KJun 15, 2026Filing
  • Insider buyInsider Buy $2KDizon Romeo R · Chief Financial Officer · $1.9KJun 12, 2026Filing
  • Insider buyInsider Buy $3KDizon Romeo R · Chief Financial Officer · $2.7KJun 9, 2026Filing
  • Insider buyInsider Buy $3KDizon Romeo R · Chief Financial Officer · $2.9KJun 8, 2026Filing
  • Insider buyInsider Buy $3KDizon Romeo R · Chief Financial Officer · $2.8KJun 3, 2026Filing
  • Insider buyInsider Buy $5KDizon Romeo R · Chief Financial Officer · $5KMay 26, 2026Filing
  • 8-K eventEarnings ReleaseMay 19, 2026Filing
  • Quarterly report10-Q FiledMay 19, 2026Filing
  • Annual report10-K FiledApr 2, 2026Filing

Questions

Frequently asked questions

What is IRIDEX Corporation's market cap?

IRIDEX Corporation (IRIX) has a market capitalization of $17.6M.

What is IRIX's P/E ratio?

A meaningful P/E ratio is not available for IRIX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is IRIX's price-to-book (P/B) ratio?

IRIX trades at 3.57 times book value per share.

When did IRIDEX Corporation last report earnings?

IRIX last reported earnings on May 19, 2026; the next date is not yet scheduled.

Are insiders buying IRIX stock?

Yes — SEC Form 4 filings show 6 open-market insider buys and 0 sells at IRIDEX Corporation in the last 90 days.

Same arena

Related companies in Medical - Devices

HYPD

Hyperion DeFi, Inc.

$17.9M

ICCM

IceCure Medical Ltd

$14.7M

COCH

Envoy Medical, Inc.

$14.5M

LFWD

Lifeward Ltd.

$12.3M

NXL

Nexalin Technology, Inc.

$11.9M

ADGM

Adagio Medical Holdings, Inc.

$11.4M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.